William Blair Upgrades ResMed (RMD) to Outperform

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/13/2026

1. WDAY
2. AAPL
3. JNJ
4. AMAT
5. META
6. NRIX
7. SUNS
8. SPY
9. SNDX
10. CRDO

Go back to William Blair Upgrades ResMed (RMD) to Outperform

ResMed (RMD) PT Lifted to $57 on Solid Q1

October 24, 2014 11:23 AM EDT

Piper Jaffray analyst David Clair reiterated an Overweight rating and boosted his price target on ResMed (NYSE: RMD) price target of $57.00 (from $55.00) following solid Q1 results.

Clair commented, "ResMed reported 1Q15 revenue of $380.4M, above consensus' $374.8M and our $373.3M... More

ResMed (RMD) Reports In-Line Q1 EPS

October 23, 2014 4:20 PM EDT

ResMed (NYSE: RMD) reported Q1 EPS of $0.58, in-line with the analyst estimate of $0.58. Revenue for the quarter came in at $380.4 million versus the consensus estimate of $375 million.

For earnings history and earnings-related data on ResMed (RMD) click here.

... More